Koufman J A
Department of Otolaryngology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.
Laryngoscope. 1991 Apr;101(4 Pt 2 Suppl 53):1-78. doi: 10.1002/lary.1991.101.s53.1.
Occult (silent) gastroesophageal reflux disease (GER, GERD) is believed to be an important etiologic factor in the development of many inflammatory and neoplastic disorders of the upper aerodigestive tract. In order ot test this hypothesis, a human study and an animal study were performed. The human study consisted primarily of applying a new diagnostic technique (double-probe pH monitoring) to a population of otolaryngology patients with GERD to determine the incidence of overt and occult GERD. The animal study consisted of experiments to evaluate the potential damaging effects of intermittent GER on the larynx. Two hundred twenty-five consecutive patients with otolaryngologic disorders having suspected GERD evaluated from 1985 through 1988 are reported. Ambulatory 24-hour intraesophageal pH monitoring was performed in 197; of those, 81% underwent double-probe pH monitoring, with the second pH probe being placed in the hypopharynx at the laryngeal inlet. Seventy percent of the patients also underwent barium esophagography with videofluoroscopy. The patient population was divided into seven diagnostic subgroups: carcinoma of the larynx (n = 31), laryngeal and tracheal stenosis (n = 33), reflux laryngitis (n = 61), globus pharyngeus (n = 27), dysphagia (n = 25), chronic cough (n = 30), and a group with miscellaneous disorders (n = 18). The most common symptoms were hoarseness (71%), cough (51%), globus (47%), and throat clearing (42%). Only 43% of the patients had gastrointestinal symptoms (heartburn or acid regurgitation). Thus, by traditional symptomatology, GER was occult or silent in the majority of the study population. Twenty-eight patients (12%) refused or could not tolerate pH monitoring. Of the patients undergoing diagnostic pH monitoring, 62% had abnormal esophageal pH studies, and 30% demonstrated reflux into the pharynx. The results of diagnostic pH monitoring for each of the subgroups were as follows (percentage with abnormal studies): carcinoma (71%), stenosis (78%), reflux laryngitis (60%), globus (58%), dysphagia (45%), chronic cough (52%), and miscellaneous (13%). The highest yield of abnormal pharyngeal reflux was in the carcinoma group and the stenosis group (58% and 56%, respectively). By comparison, the diagnostic barium esophagogram with videofluoroscopy was frequently negative. The results were as follows: esophagitis (18%), reflux (9%), esophageal dysmotility (12%), and stricture (3%). All of the study patients were treated with antireflux therapy. Follow-up was available on 68% of the patients and the mean follow-up period was 11.6 +/- 12.7 months.(ABSTRACT TRUNCATED AT 400 WORDS)
隐匿性(无症状)胃食管反流病(GER,GERD)被认为是上呼吸道消化道许多炎症性和肿瘤性疾病发生发展的一个重要病因。为了验证这一假说,进行了一项人体研究和一项动物研究。人体研究主要是将一种新的诊断技术(双探头pH监测)应用于一组患有GERD的耳鼻喉科患者,以确定显性和隐匿性GERD的发生率。动物研究包括评估间歇性GER对喉部潜在损害作用的实验。报告了1985年至1988年期间连续评估的225例怀疑患有GERD的耳鼻喉科疾病患者。197例患者进行了24小时动态食管pH监测;其中81%接受了双探头pH监测,第二个pH探头置于喉入口处的下咽。70%的患者还接受了钡剂食管造影及电视透视检查。患者群体分为七个诊断亚组:喉癌(n = 31)、喉气管狭窄(n = 33)、反流性喉炎(n = 61)、咽异感症(n = 27)、吞咽困难(n = 25)、慢性咳嗽(n = 30)以及一组患有其他杂症的患者(n = 18)。最常见的症状是声音嘶哑(71%)、咳嗽(51%)、咽部异物感(47%)和清嗓(42%)。只有43%的患者有胃肠道症状(烧心或反酸)。因此,按照传统症状学,在大多数研究人群中GER是隐匿性或无症状的。28例患者(12%)拒绝或无法耐受pH监测。在接受诊断性pH监测的患者中,62%的食管pH研究异常,30%显示有反流至咽部。各亚组诊断性pH监测结果如下(研究异常的百分比):癌症(71%)、狭窄(78%)、反流性喉炎(60%)、咽异感症(58%)、吞咽困难(45%)、慢性咳嗽(52%)以及其他杂症(13%)。咽部反流异常检出率最高的是癌症组和狭窄组(分别为58%和56%)。相比之下,诊断性钡剂食管造影及电视透视检查结果常为阴性。结果如下:食管炎(18%)、反流(9%)、食管动力障碍(12%)和狭窄(3%)。所有研究患者均接受了抗反流治疗。68%的患者有随访资料,平均随访期为11.6±12.7个月。(摘要截选至400字)